Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case–control study
Abstract Background Patients who receive percutaneous coronary intervention (PCI) have different chances of developing in-stent restenosis (ISR). To date, no predictable biomarker can be applied in the clinic. MicroRNAs (miRNAs or miRs) play critical roles in transcription regulation, and their circ...
Main Authors: | Chun-Hsu Pan, Shu-Chen Chien, Chang-Jui Chen, Chun-Ming Shih, Ming-Hsiung Hsieh, Chun-Yao Huang, Wei-Fung Bi, Chao-Shun Chan, Yung-Ta Kao, Cheng-Yi Hsiao, Shuo-Ju Chiang, Kuang-Hsing Chiang, Jen-Hung Huang, Yun-Ru Liu, Ji-Dung Luo, Hui-Yu Huang, Chieh-Hsi Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-021-01893-y |
Similar Items
-
In-Stent Restenosis
by: Anna Lena Lahmann, MD, et al.
Published: (2020-01-01) -
Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01) -
Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005-10-01) -
In-stent restenosis. Acute and long-term outcomes after excimer laser coronary angioplasty
by: Jorge Bejarano, et al.
Published: (1999-08-01) -
Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
by: Emrah Erdogan, et al.
Published: (2022-11-01)